Burcon Announces Receipt of Nasdaq Letter Regarding Deficiency in Compliance With Certain Listing Rules
2018年2月28日 - 6:40AM
Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon” or
the “Company”), a leader in natural product extraction,
purification and isolation technologies, announced that on February
21, 2018, the Company received notification from the Listing
Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ")
stating that the Company did not meet NASDAQ's February 19, 2018
deadline to regain compliance with NASDAQ Listing Rule 5450(a)(1),
which requires the listed securities of the Company to maintain a
minimum bid price of US$1 per share.
The NASDAQ notification letter does not result
in the immediate delisting of the Company's common shares, and the
shares will continue to trade uninterrupted under the symbol
"BUR."
On February 5, 2018, the Company announced that
it received notification from the Nasdaq Hearings Panel (the
“Panel”) that the Panel had granted approval of Burcon’s request to
transfer its listing to the NASDAQ Capital Market (the “Capital
Market”) from the NASDAQ Global Market. The Company’s common
shares commenced trading on the Capital Market on February 7,
2018. The Panel subjected the continued listing of the
Company’s common shares on the Capital Market to certain
conditions, including closing its rights offering and having
shareholders’ equity of over US$2.5 million on or before February
16, 2018 and to provide the Panel with regular updates. Upon
closing of the rights offering, the Company expected that it would
be granted an additional 180-day grace period to regain compliance
with NASDAQ’s minimum bid price requirement. However, because
the Company’s rights offering that closed on February 13, 2018 was
not fully subscribed, the Company was not automatically eligible
for the additional 180-grace period.
NASDAQ’s February 21, 2018 letter states that
the Panel will consider the failure of the Company to regain
compliance with NASDAQ Listing Rule 5450(a)(1) in its decision
regarding the Company’s continued listing on the Capital
Market. The Company has the ability to present its view with
respect to this deficiency to the Panel in writing no later than
March 5, 2018.
Burcon’s management is reviewing various options
available to the Company in order to maintain its listing on the
Capital Market.
About Burcon NutraScience
Corporation
Burcon is a leader in developing technologies
for the production of valuable plant-sourced ingredients for use in
food, nutrition, wellness and supplement products. The company has
developed a portfolio of composition, application, and process
patents originating from a core protein extraction and purification
technology. Burcon’s CLARISOY™ soy protein offers clarity and
high-quality protein nutrition for low pH beverage systems and
excellent solubility and exceptionally clean flavor at any pH;
Peazazz® is a uniquely soluble and clean-tasting pea protein; and
Puratein®, Supertein® and Nutratein® are canola protein isolates
with unique functional and nutritional attributes. Burcon is
also conducting research to develop extraction and isolation
processes for the production of purified cannabinoid extracts from
cannabis and other organic source materials. For more
information about the company, visit www.burcon.ca.
The TSX has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements or forward-looking information within the meaning of the
U.S. Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities legislation. Forward-looking
statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking statements.
Forward- looking statements or forward-looking information can be
identified by words such as “anticipate,” “intend,” “plan,” “goal,”
“project,” “estimate,” “expect,” “believe”, “future,” “likely,”
“may,” “should,” “could”, “will” and similar references to future
periods. All statements other than statements of historical fact
included in this release are forward-looking statements, including,
without limitation, statements regarding the ability of the Company
to regain and maintain compliance with the requirements of The
Nasdaq Capital Market and other expectations, intentions and plans
contained in this press release. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements or information. Important factors that could cause
actual results to differ materially from Burcon’s plans and
expectations include the actual results of business negotiations,
marketing activities, adverse general economic, market or business
conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with
securities regulators and stock exchanges, including in the section
entitled “Risk Factors” in Burcon’s annual information form dated
June 21, 2017 filed with the Canadian securities administrators on
www.sedar.com and contained in Burcon’s 20-F filed with the U.S.
Securities and Exchange Commission on www.sec.gov. Any
forward-looking statement or information only speaks as of the date
on which it was made and, except as may be required by applicable
securities laws, Burcon disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new
information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance, and accordingly, investors should not rely on such
statements.
CLARISOY is a trademark of Archer Daniels Midland Company.
Media & Industry
Contact:
Paul LamManager, Business DevelopmentBurcon NutraScience
CorporationTel (604) 733-0896, Toll-free (888)
408-7960plam@burcon.ca www.burcon.ca
Burcon NutraScience (TSX:BU)
過去 株価チャート
から 11 2024 まで 12 2024
Burcon NutraScience (TSX:BU)
過去 株価チャート
から 12 2023 まで 12 2024